JPH04295849A - Developer for planographic printing plate - Google Patents

Developer for planographic printing plate

Info

Publication number
JPH04295849A
JPH04295849A JP8609991A JP8609991A JPH04295849A JP H04295849 A JPH04295849 A JP H04295849A JP 8609991 A JP8609991 A JP 8609991A JP 8609991 A JP8609991 A JP 8609991A JP H04295849 A JPH04295849 A JP H04295849A
Authority
JP
Japan
Prior art keywords
group
developer
development
formula
silver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8609991A
Other languages
Japanese (ja)
Other versions
JP2938997B2 (en
Inventor
Takimi Hashimoto
橋本 滝美
Taketoshi Miura
偉俊 三浦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Paper Mills Ltd
Original Assignee
Mitsubishi Paper Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Paper Mills Ltd filed Critical Mitsubishi Paper Mills Ltd
Priority to JP8609991A priority Critical patent/JP2938997B2/en
Publication of JPH04295849A publication Critical patent/JPH04295849A/en
Application granted granted Critical
Publication of JP2938997B2 publication Critical patent/JP2938997B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Photosensitive Polymer And Photoresist Processing (AREA)

Abstract

PURPOSE:To improve plate wear and to obtain silver images having high ink acceptability by incorporating a specific compd. and an org. development inhibitor without contg. mercapto groups into the above developer. CONSTITUTION:The physical development accelerator expressed by formula I and the org. development inhibitor without having the mercapto groups are used in combination in the development processing liquid in the development of a direct planographic printing plate for which a silver complex salt diffusion transfer method is utilized. In the formula I, R denotes an alkyl group, allyl group, aralkyl group, hydroxyalkyl group; X denotes a hetero atom of Se, S, O, N or is a methylene group, alkyl substd. methylene group; Z denotes the atom group necessary for forming a 5-membered ring or 6-membered ring. The compd. expressed by the formula I can be easily synthesized and the amt. of this compd. to be added to the developer is preferably in a 0.01 to 10.0wt.% range, more preferably in a 0.01 to 4.0wt.% range. Benzotriazole or benzimidazole and its deriv. are particularly effective as the org. development inhibitor which has no mercapto groups and is to be used in combination.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は銀錯塩拡散転写法による
平版印刷版に用いる現像液に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a developer used for lithographic printing plates produced by silver complex diffusion transfer.

【0002】0002

【従来の技術】銀錯塩拡散転写法(DTR)によって得
られる銀画像を利用したオフセット印刷版は、既に特許
公報昭46−43132号あるいは特許公報昭48−3
0562号に記載されており、さらにポジタイプの印刷
原版については公開特許公報昭49−55402号に、
ネガタイプの印刷原版については公開特許公報昭52−
106902号、公開特許公報昭52−112402号
等に詳細に記載されている。
[Prior Art] An offset printing plate using a silver image obtained by the silver complex diffusion transfer method (DTR) has already been disclosed in Patent Publication No. 46-43132 or Patent Publication No. 48-3.
0562, and the positive type printing original plate is described in Published Patent Publication No. 1983-55402.
Regarding negative type printing plates, see the published patent publication 1972-
It is described in detail in No. 106902, Japanese Patent Publication No. 112402/1980, and the like.

【0003】これらのダイレクト印刷版は、支持体およ
びその上にハレーション防止をかねた下引層、ハロゲン
化銀乳剤層、物理現像核層からなっている。感光材料を
像様露光後、現像薬とハロゲン化銀溶剤を含む現像液で
処理すると潜像が形成されているハロゲン化銀は乳剤層
中で黒化銀となるが、これに対して潜像が形成されてい
ないハロゲン化銀はハロゲン化銀錯化剤の作用で溶解し
、感光材料の表面に拡散してくる。この銀錯塩が表面層
の物理現像核の上に現像主薬の還元作用によって銀画像
として析出するプロセスによって印刷版が得られる。 この銀画像のインキ受容性を強化させるためには現像後
、必要ならば感脂化処理を施し、オフセット印刷機上で
印刷物へとインキ画像が転写される。このダイレクト印
刷版は、操作性が良い、低価格等の利点を持っているが
、反面写真現像処理により印刷用銀画像を形成する性格
上、処理時間内に拡散転写が完結せず、その結果、過剰
な銀イオンが残存し、それが保存安定性もしくは耐刷力
低下の1原因となっていた。
These direct printing plates consist of a support, and thereon a subbing layer for antihalation, a silver halide emulsion layer, and a physical development nucleus layer. When a photosensitive material is imagewise exposed and then treated with a developer containing a developer and a silver halide solvent, the silver halide forming a latent image becomes blackened silver in the emulsion layer; The unformed silver halide is dissolved by the action of the silver halide complexing agent and diffused onto the surface of the photosensitive material. A printing plate is obtained by a process in which this silver complex salt is deposited as a silver image on the physical development nuclei of the surface layer by the reducing action of a developing agent. In order to enhance the ink receptivity of this silver image, after development, if necessary, a sensitizing treatment is applied and the ink image is transferred to a printed product on an offset printing press. This direct printing plate has advantages such as good operability and low price, but on the other hand, because the silver image for printing is formed by photo development processing, the diffusion transfer cannot be completed within the processing time, resulting in However, excessive silver ions remained, which was one of the causes of decreased storage stability or printing durability.

【0004】これらの欠点を改良するために種々の方法
が利用される。その一つは、酸化剤の使用である。特開
昭55−98753号には、含イオウ有機化合物と酸化
剤の併用が述べられており、また、特開昭51−589
52号、同昭61−223740号には、ヨウ素イオン
と酸化剤を使った耐刷力の向上法が述べられている。ま
た、キレート樹脂の利用による過剰な銀イオンの除去も
、耐刷力を上げるには効果があった。しかしながら、こ
れらの方法の欠点は、往々にして銀画像のインキ受理能
を低下させる傾向がある事であった。また、特開昭57
−211148号、同昭58−156936号には、物
理現像促進剤としてチオン化合物の使用する方法が述べ
られている。これらの方法は、インクのり、耐刷力の点
で上記の方法より優れているが、写真的な不利な特性の
変化、例えば軟調化など引き起こし、その結果、耐刷力
の低下が起こることであった。
Various methods are available to remedy these shortcomings. One of them is the use of oxidizing agents. JP-A No. 55-98753 describes the use of a sulfur-containing organic compound and an oxidizing agent in combination, and JP-A No. 51-589
No. 52 and No. 61-223740 describe a method for improving printing durability using iodine ions and an oxidizing agent. Additionally, removing excess silver ions by using a chelate resin was also effective in increasing printing durability. However, a drawback of these methods was that they often tended to reduce the ink receptivity of the silver image. In addition, JP-A-57
No. 211148 and No. 58-156936 describe methods of using thione compounds as physical development accelerators. Although these methods are superior to the above methods in terms of ink adhesion and printing durability, they may cause disadvantageous changes in photographic properties, such as softening of the tone, resulting in a decrease in printing durability. there were.

【0005】[0005]

【発明が解決しようとする課題】本発明の目的は、銀錯
塩拡散転写法を利用するダイレクト平版印刷版の現像に
おいて耐刷力の良好で、インキ受理能の高い銀画像を得
るための処理液を提供することである。
[Problems to be Solved by the Invention] An object of the present invention is to provide a processing solution for obtaining a silver image with good printing durability and high ink receptivity in the development of a direct lithographic printing plate using the silver complex diffusion transfer method. The goal is to provide the following.

【0006】[0006]

【課題を解決するための手段】本発明の目的は、上記現
像処理液中に、化2で表される物理現像促進剤を少なく
とも1種と、メルカプト基を有しない有機現像抑制剤を
併用する事で達成された。
[Means for Solving the Problems] An object of the present invention is to use at least one physical development accelerator represented by the formula 2 and an organic development inhibitor having no mercapto group in the development processing solution. It was achieved by this.

【0007】[0007]

【化2】[Case 2]

【0008】式中、Rはアルキル基、アリル基、アラル
キル基、ヒドロキシアルキル基を示し、XはSe,S、
O、Nのヘテロ原子または、メチレン基、アルキル置換
メチレン基であり、Zは5員環又は6員環を形成するた
めに必要な残りの原子群を示す。
In the formula, R represents an alkyl group, an allyl group, an aralkyl group, or a hydroxyalkyl group, and X represents Se, S,
It is a hetero atom of O or N, a methylene group, or an alkyl-substituted methylene group, and Z represents the remaining atomic group necessary to form a 5-membered ring or a 6-membered ring.

【0009】本発明に用いられる化2の化合物の代表的
な具体例を以下に示す。
Typical examples of the compound of formula 2 used in the present invention are shown below.

【0010】0010

【化3】[Chemical formula 3]

【0011】[0011]

【化4】[C4]

【0012】0012

【化5】[C5]

【0013】[0013]

【化6】[C6]

【0014】[0014]

【化7】[C7]

【0015】[0015]

【化8】[Chemical formula 8]

【0016】[0016]

【化9】[Chemical formula 9]

【0017】[0017]

【化10】[Chemical formula 10]

【0018】[0018]

【化11】[Chemical formula 11]

【0019】[0019]

【化12】[Chemical formula 12]

【0020】[0020]

【化13】[Chemical formula 13]

【0021】[0021]

【化14】[Chemical formula 14]

【0022】[0022]

【化15】[Chemical formula 15]

【0023】[0023]

【化16】[Chemical formula 16]

【0024】[0024]

【化17】[Chemical formula 17]

【0025】[0025]

【化18】[Chemical formula 18]

【0026】[0026]

【化19】[Chemical formula 19]

【0027】[0027]

【化20】[C20]

【0028】[0028]

【化21】[C21]

【0029】[0029]

【化22】[C22]

【0030】これらの化合物は、例えばジャーナル・オ
ブ・オ−ガニック・ケミストリー36巻  637頁(
1971年)[J.Org.Chem.36  637
(1971)]、シンセシス  807頁(1984年
)[Synthesis807(1971)]、シンセ
シス  96頁(1983年)[Synthesis 
 96(1971)]、ケミカル・ファーマスーティカ
ル・ブリテン  31巻1733頁(1983年)[C
hem・Pharm・Bull  31  1733(
1983)]、オーガニック・シンセス  7巻  1
95頁[Organic・Synthesis,Col
l.vol.  7  195(1990)]、特開昭
62−246558等の方法により容易に合成すること
ができる。本発明の化2の化合物の現像液への添加量は
、重量%で0.01〜10.0重量%の範囲であり、特
に0.01〜4.0重量%の範囲が好ましく、単独又は
2種以上の化合物の併用もできる。
These compounds are described, for example, in Journal of Organic Chemistry, Vol. 36, p. 637 (
1971) [J. Org. Chem. 36 637
(1971)], Synthesis p. 807 (1984) [Synthesis 807 (1971)], Synthesis p. 96 (1983) [Synthesis
96 (1971)], Chemical Pharmaceutical Bulletin Vol. 31, p. 1733 (1983) [C
hem・Pharm・Bull 31 1733 (
1983)], Organic Synthes Vol. 7, 1
Page 95 [Organic Synthesis, Col.
l. vol. 7 195 (1990)] and JP-A-62-246558. The amount of the compound of chemical formula 2 of the present invention added to the developer is in the range of 0.01 to 10.0% by weight, particularly preferably in the range of 0.01 to 4.0% by weight, and can be used alone or Two or more types of compounds can also be used in combination.

【0031】また本発明の処理液に併用するメルカプト
基を有しない有機現像抑制剤は、単独でも2種以上併用
してもよく、メルカプト基を有しない化合物であればな
んでも良いが、ベンゾトリアゾール又はベンズイミダゾ
ールとその誘導体が特に効果的であった。本発明に用い
られる有機現像抑制剤とは、メルカプト基を有しない化
合物であり、代表的な具体例を以下に示す。
[0031] The organic development inhibitor having no mercapto group used in the processing solution of the present invention may be used alone or in combination of two or more, and any compound having no mercapto group may be used, but benzotriazole or Benzimidazole and its derivatives were particularly effective. The organic development inhibitor used in the present invention is a compound having no mercapto group, and typical examples are shown below.

【0032】[0032]

【化23】[C23]

【0033】[0033]

【化24】[C24]

【0034】[0034]

【化25】[C25]

【0035】[0035]

【化26】[C26]

【0036】[0036]

【化27】[C27]

【0037】有機現像抑制剤の処理液への添加量は重量
比で、0.01〜2.0重量%が良く、化2との比は重
量比で0.01〜1.0重量%が好ましい。
The amount of the organic development inhibitor added to the processing solution is preferably 0.01 to 2.0% by weight, and the ratio with chemical formula 2 is preferably 0.01 to 1.0% by weight. preferable.

【0038】平版印刷版用拡散転写現像液にカルボキシ
メチルセルロース(CMC)、ヒドロキシエチルセルロ
ース(HEC)等の水溶性ポリマーを粘稠剤として使用
することは公知であり(例えば特開昭48−76603
、同昭56−6237等)本発明の処理液においても添
加してもよいが、これらの高分子化合物には、耐刷力を
向上させる作用はない。
It is known that water-soluble polymers such as carboxymethyl cellulose (CMC) and hydroxyethyl cellulose (HEC) are used as thickening agents in diffusion transfer developers for lithographic printing plates (for example, in Japanese Patent Application Laid-Open No. 76603/1983).
Although they may be added to the processing solution of the present invention, these polymer compounds do not have the effect of improving printing durability.

【0039】本発明現像処理液には、アルカリ性物質、
例えば水酸化ナトリウム、水酸化カリウム、第三燐酸ナ
トリウム等と保恒剤としての亜硫酸塩(亜硫酸カリウム
、亜硫酸ナトリウムなど)が必須であるが、それ以外の
化合物、例えば硫酸塩(硫酸ナトリウム、硫酸アンモニ
ウムなど)、かぶり防止剤、例えば臭化カリウム、ハロ
ゲン化銀溶剤、例えばチオ硫酸塩、チオシアン酸塩、チ
オエーテル、環状イミド、チオサリチル酸、アルカノー
ルアミン等、粘稠剤、例えばヒドロキシエチルセルロ−
ス(HEC)、カルボキセメチルセルロース(CMC)
等、現像主薬、例えばハイドロキノン、1−フェニル−
3−ピラゾリドン、メト−ル等、現像変性剤、例えばポ
リオキシアルキレン化合物、オニウム化合物等を含むこ
とができる。更に、界面活性剤、例えばアルギン酸プロ
ピレングリコールエステル、アミノポリカルボン酸塩(
エチレンジアミン四酢酸ナトリウム)等の1種又は2種
以上含有させることもできる。この他にも本発明の化合
物の溶剤、例えばメタノール、エタノール、プロパノー
ル、イソプロピルアルコール、n−ブチルアルコール、
ジメチルホルムアルデヒド、ジオキサン等の水混和性有
機溶剤を含ませることができる。
The developing solution of the present invention contains an alkaline substance,
For example, sodium hydroxide, potassium hydroxide, sodium triphosphate, etc. and sulfites as preservatives (potassium sulfite, sodium sulfite, etc.) are essential, but other compounds such as sulfates (sodium sulfate, ammonium sulfate, etc.) are essential. ), antifoggants such as potassium bromide, silver halide solvents such as thiosulfates, thiocyanates, thioethers, cyclic imides, thiosalicylic acid, alkanolamines, etc., thickening agents such as hydroxyethyl cellulose
(HEC), carboxymethyl cellulose (CMC)
etc., developing agents such as hydroquinone, 1-phenyl-
3-pyrazolidone, methol, etc., development modifiers such as polyoxyalkylene compounds, onium compounds, etc. can be included. Furthermore, surfactants such as alginate propylene glycol ester, aminopolycarboxylic acid salts (
It is also possible to contain one or more types such as sodium ethylenediaminetetraacetate). In addition, there are other solvents for the compounds of the present invention, such as methanol, ethanol, propanol, isopropyl alcohol, n-butyl alcohol,
Water-miscible organic solvents such as dimethyl formaldehyde and dioxane can be included.

【0040】錯塩拡散転写法の実施に当っては、例えば
英国特許第1,000,115号、第1,012,47
6号、第1,017,273号、第1,042,477
号の明細書に記載されている如く、ハロゲン化銀乳剤層
および/または受像層またはそれに隣接する他の水透過
性層中に現像主薬を混入することが行われている。従っ
て、このような感光材料では、現像に使われる処理液は
、現像主薬を含まぬ所謂「アルカリ性活性化液」を使用
しうる。本発明の処理液は、この様なタイプの感材でも
効果がある。
In carrying out the complex salt diffusion transfer method, for example, British Patent Nos. 1,000,115 and 1,012,47
No. 6, No. 1,017,273, No. 1,042,477
It has been practiced to incorporate developing agents into the silver halide emulsion layer and/or into the image-receiving layer or other water-permeable layers adjacent thereto. Therefore, in such a photosensitive material, a so-called "alkaline activating solution" which does not contain a developing agent may be used as a processing solution for development. The processing liquid of the present invention is also effective for these types of photosensitive materials.

【0041】また本発明の実施に用いられる平版印刷版
のハロゲン化銀乳剤は塩化銀、臭化銀、塩臭化銀、塩ヨ
ウ化銀、塩臭ヨウ化銀が使用でき、好ましくは塩化銀が
50モル%以上のハロゲン化銀である。これらのハロゲ
ン化銀乳剤は分光増感剤(光源、用途に応じた分光増感
色素、例えばカメラタイプ、レーザー光タイプ、色分解
用パンクロタイプ等)、ゼラチン硬化剤、塗布助剤、カ
ブリ防止剤、可塑剤、現像主薬、マット剤などを含むこ
とが出来る。
The silver halide emulsion of the lithographic printing plate used in carrying out the present invention may be silver chloride, silver bromide, silver chlorobromide, silver chloroiodide, or silver chlorobromoiodide, and silver chloride is preferable. is 50 mol% or more of silver halide. These silver halide emulsions contain spectral sensitizers (spectral sensitizing dyes depending on the light source and application, such as camera type, laser light type, panchromatic type for color separation, etc.), gelatin hardeners, coating aids, and antifoggants. , a plasticizer, a developing agent, a matting agent, etc.

【0042】本発明の平版印刷版のハロゲン化銀乳剤に
用いられるバインダーは、通常ゼラチンであるが、ゼラ
チンは、その一部をデンプン、アルブミン、アルギン酸
ナトリウム、ヒドロキシエチルセルロース(HEC)、
アラビアゴム、ポリビニルアルコール(PVA)、ポリ
ビニルピロリドン(PVP)、カルボキシメチルセルロ
ース(CMC)、ポリアクリルアミド、スチレン−無水
マレイン酸共重合体、ポリビニルメチルエーテル−無水
マレイン酸共重合体などの親水性高分子結合剤の一種ま
たは二種以上で置換することもできる。さらにビニル共
重合体水分散物(ラテックス)を用いることもできる。
The binder used in the silver halide emulsion of the lithographic printing plate of the present invention is usually gelatin, and gelatin is partially composed of starch, albumin, sodium alginate, hydroxyethyl cellulose (HEC),
Hydrophilic polymer bonds such as gum arabic, polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), carboxymethylcellulose (CMC), polyacrylamide, styrene-maleic anhydride copolymer, polyvinyl methyl ether-maleic anhydride copolymer, etc. It can also be replaced with one or more agents. Furthermore, a vinyl copolymer aqueous dispersion (latex) can also be used.

【0043】ハロゲン化銀乳剤層の下側(支持体面)に
は接着改良下引層及び又はハレーション防止等の目的で
下塗層を含むことも出来、この層には現像主薬、マット
剤、を含むことが出来る。
The underside (support side) of the silver halide emulsion layer may contain an undercoat layer for the purpose of improving adhesion and/or preventing halation, and this layer may contain a developing agent, a matting agent, etc. can be included.

【0044】ハロゲン化銀乳剤を塗布する支持体は、紙
、各種のフィルム、プラスチックス、樹脂様物質を塗布
した紙、金属板等が使用出来る。
As the support to which the silver halide emulsion is coated, paper, various films, plastics, paper coated with a resin-like substance, metal plate, etc. can be used.

【0045】物理現像核層に使用される物理現像核は、
この種の薬品は周知であって、アンチモン、カドミウム
、コバルト、パラジウム、ニッケル、銀、鉛、亜鉛、等
の金属及びその硫化物が使用できる。この物理現像核層
にも現像主薬を含むこともできるし、親水性バインダー
を含んでもよい。
The physical development nuclei used in the physical development nucleus layer are:
Chemicals of this type are well known and can include metals such as antimony, cadmium, cobalt, palladium, nickel, silver, lead, zinc, and their sulfides. This physical development nucleus layer may also contain a developing agent or a hydrophilic binder.

【0046】[0046]

【実施例】以下に本発明を実施例により具体的に説明す
るが、勿論、これだけに限定されるものではない。
[Examples] The present invention will be specifically explained below using examples, but it is of course not limited thereto.

【0047】実施例1 下引処理したポリエステルフィルム支持体の片面に平均
粒子サイズ5μのシリカ粒子を含有するマット化層を設
け、反対側の面に633nmの光反射率3%になる量の
カーボンブラックを含み、写真用ゼラチンに対して20
重量%の平均粒径7μmのシリカ粉末を含むハレーショ
ン防止用下塗層(pH4.0に調整)と、化学増感され
た後に平均粒径7μmのシリカ粉末を写真用ゼラチンに
対して5重量%の割合で含む分光増感された高感度塩化
銀乳剤(pH4.0に調整)とを設けた。下塗層のゼラ
チンは3.5g/m2 、乳剤層のゼラチンは0.8g
/m2 、硝酸銀に換算したハロゲン化銀1.0g/m
2 の割合で塗布された。この下塗層と乳剤層は硬膜剤
としてホルマリンをゼラチンに対して5.0mg/gの
量で含んでいる。乾燥後40℃で14日間加温した後、
この乳剤層の上に、特開昭54−103104実施例2
のプレートNo.31記載の核液を塗布、乾燥し、平版
印刷版を製造する。ハロゲン化銀乳剤は、物理熟成時に
ハロゲン化銀1モル当たり4×10−6モルの塩化ロジ
ウムを添加したものであり、平均粒径0.40ミクロン
であった。 このようにして得られた平版印刷版の原版に像反転機構
を有する製版カメラで像露光し、下記の現像液A(使用
液)により30℃で30秒間現像処理し、続いて下記中
和液で処理した。
Example 1 A matting layer containing silica particles with an average particle size of 5 μm was provided on one side of a subbed-treated polyester film support, and an amount of carbon was applied on the opposite side to give a light reflectance of 3% at 633 nm. Contains black, 20% for photographic gelatin
An antihalation subbing layer (adjusted to pH 4.0) containing silica powder with an average particle size of 7 μm in weight% and 5% by weight of silica powder with an average particle size of 7 μm on photographic gelatin after being chemically sensitized. A spectrally sensitized high-sensitivity silver chloride emulsion (adjusted to pH 4.0) was prepared. Gelatin in the undercoat layer is 3.5g/m2, and gelatin in the emulsion layer is 0.8g.
/m2, silver halide converted to silver nitrate 1.0g/m2
It was applied at a ratio of 2. The undercoat layer and emulsion layer contained formalin as a hardening agent in an amount of 5.0 mg/g based on gelatin. After drying and heating at 40°C for 14 days,
On this emulsion layer, JP-A-54-103104 Example 2
Plate No. A lithographic printing plate is produced by applying the nuclear solution described in 31 and drying it. The silver halide emulsion had 4 x 10-6 mol of rhodium chloride added per mol of silver halide during physical ripening, and had an average grain size of 0.40 microns. The lithographic printing plate master obtained in this manner was image-exposed using a plate-making camera having an image reversal mechanism, and developed with the following developer A (working solution) at 30°C for 30 seconds, followed by the following neutralizing solution. Processed with.

【0048】   現像液A   水酸化ナトリウム               
                         
24g  水酸化カリウム             
                         
      8g  無水亜硫酸ナトリウム     
                         
      50g  2−メチル−2−アミノ−1−
プロパノール                30g
  ウラシル                   
                         
  0.2g  水を加えて1lとする。
Developer solution A Sodium hydroxide

24g potassium hydroxide

8g anhydrous sodium sulfite

50g 2-methyl-2-amino-1-
Propanol 30g
Uracil

Add 0.2g water to make 1L.

【0049】   中和液   エチレングリコール              
                         
 5g  コロイダルシリカ(20%水溶液)    
                      1g 
 クエン酸                    
                         
   10g  クエン酸ナトリウム        
                         
     35g  水を加えて1lとする。
Neutralizing liquid ethylene glycol

5g colloidal silica (20% aqueous solution)
1g
citric acid

10g sodium citrate

Add 35g water to make 1L.

【0050】一方、前記の現像液Aを比較として本発明
の例示化合物化3と有機現像抑制剤を添加し現像液B−
Hを調製した。但し、現像液Cは、比較例としてメルカ
プト基を含有する抑制剤である代表的な化合物、下記化
28を使用した。現像は上記の現像液Aと全く同様に製
版処理した。ついで印刷版をオフセット印刷機にセット
し、下記組成のエッチ液で版面を充分に湿し、下記組成
の給湿液を用いて印刷を行った。
On the other hand, as a comparison of the above developer A, a developer B- was prepared by adding Exemplified Compound 3 of the present invention and an organic development inhibitor.
H was prepared. However, as a comparative example, developer C used the following chemical compound 28, which is a typical compound that is a mercapto group-containing inhibitor. Development was carried out in exactly the same manner as developer A described above. The printing plate was then set in an offset printing machine, the plate surface was sufficiently moistened with an etchant having the composition shown below, and printing was carried out using a dampening liquid having the composition shown below.

【0051】   エッチ液   水                      
                         
     600ml  イソプロパノール     
                         
        400ml  エチレングリコール 
                         
            50g
Etch liquid water

600ml isopropanol

400ml ethylene glycol

50g

【0052】   給湿液   水                      
                         
         8l  コハク酸        
                         
                 6g  硫酸ナト
リウム                      
                    25g  
エチレングリコール                
                    100g 
 コロイダルシリカ(20%水溶液)        
                28g
Moisturizing liquid water

8l succinic acid

6g sodium sulfate
25g
ethylene glycol
100g
Colloidal silica (20% aqueous solution)
28g

【0053】
印刷機はエー・ビー・ディック350CD(A・B・D
ick社製オフセット印刷機の商標)を使用した。現像
液Aで得られた印刷版は、5,000枚、現像液Bで得
られた印刷版は、10,000枚までに転写銀像の部分
的な欠落が生じたのに対して、本発明の現像液D・Eで
得られた印刷版は、25,000枚、F〜Hで得られた
印刷版は、50,000枚でも転写銀像の欠落は生じな
かった。
[0053]
The printing machine was an A.B. Dick 350CD (A.B.D.
An offset printing machine (trademark) manufactured by IKE Co., Ltd. was used. The printing plate obtained with developer A showed partial loss of the transferred silver image by 5,000 sheets, and the printing plate obtained with developer B showed partial loss of the transferred silver image by 10,000 sheets. The printing plates obtained using the developing solutions D and E of the invention did not cause any loss of the transferred silver image even after 25,000 sheets were printed, and the printing plates obtained using the developing solutions F to H did not cause any loss even after 50,000 sheets were printed.

【0054】[0054]

【表1】[Table 1]

【0055】実施例1で使用した化3とメルカプト基を
有しない有機抑制剤化23(添加量0,19g/l)を
組み合わせた結果を表1に、以下の基準により判定した
印刷結果を示した。印刷の耐刷力は、1,000枚以上
50,000枚までの印刷を続け、銀画像部のインキと
びのでるときの印刷枚数によって、次の4つの水準で評
価した。 A    50,000以上 B    25,000 C    10,000 D      5,000
Table 1 shows the results of combining Compound 3 used in Example 1 and organic inhibitor 23 (addition amount 0.19 g/l) having no mercapto group, and shows the printing results judged according to the following criteria. Ta. The printing durability of printing was evaluated on the following four levels based on the number of printed sheets when ink splattered in the silver image area after continuous printing of 1,000 to 50,000 sheets. A 50,000 or more B 25,000 C 10,000 D 5,000

【0056】実施例2 実施例1の現像液Dで用いた有機抑制剤化23(添加量
  0,19g/l)と化3の代わりに、化4〜化22
を各々、0.5g/l添加し、現像液1〜19を調製し
た以外は、上記の現像液Aと全く同様に製版処理した。 印刷の結果を表2及び表3に示す。すべて現像液Aに比
較して耐刷力が良好であった。
Example 2 In place of organic inhibitor 23 (addition amount 0.19 g/l) and compound 3 used in developer D of Example 1, compounds 4 to 22 were used.
The plate-making process was carried out in exactly the same manner as the developer A described above, except that 0.5 g/l of each was added and developers 1 to 19 were prepared. The printing results are shown in Tables 2 and 3. All had better printing durability than developer A.

【0057】[0057]

【表2】[Table 2]

【0058】[0058]

【表3】[Table 3]

【0059】表2及び表3から明らかなように化2の化
合物とメルカプト基を含んでいない有機現像抑制剤を併
用して得られた平版印刷版は、飛躍的に耐刷力の優れた
画像銀が得られ、メルカプト基を含んでいる有機現像抑
制剤により得られた平版印刷版に比べて、原稿の細線部
分も良好に再現され、しかもその細線部の印刷による機
械的磨耗もなく長い印刷に耐えるものであった。
As is clear from Tables 2 and 3, the lithographic printing plate obtained by using the compound of Chemical Formula 2 in combination with an organic development inhibitor that does not contain a mercapto group has an image with dramatically excellent printing durability. Compared to lithographic printing plates obtained using silver and organic development inhibitors containing mercapto groups, fine line areas of originals can be reproduced better, and there is no mechanical abrasion caused by printing on the fine line areas, and long printing is possible. It was durable.

【0060】本発明の現像液で製版された平版印刷版は
、転写銀像の欠落が改良され、耐刷力の飛躍的な向上が
図れ、インキ受理能の低下がない。
[0060] The lithographic printing plate made with the developer of the present invention has improved loss of transferred silver images, dramatically improves printing durability, and has no deterioration in ink receptivity.

【化28】[C28]

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】  銀錯塩拡散転写法を利用する平版印刷
版の現像液に於いて、下記式で表される化合物を少なく
とも1種類とメルカプト基を含有しない有機現像抑制剤
の少なくとも1種類とを含有することを特徴とする平版
印刷版用現像液。 【化1】 式中、Rはアルキル基、アリル基、アラルキル基、ヒド
ロキシアルキル基を示し、XはSe,S、O、Nのヘテ
ロ原子または、メチレン基、アルキル置換メチレン基で
あり、Zは5員環又は6員環を形成するために必要な残
りの原子群を示す。
Claim 1: A developer for a lithographic printing plate using a silver complex diffusion transfer method, comprising at least one compound represented by the following formula and at least one organic development inhibitor not containing a mercapto group. A developer for a lithographic printing plate characterized by containing: [Formula 1] In the formula, R represents an alkyl group, an allyl group, an aralkyl group, or a hydroxyalkyl group; The remaining atomic groups necessary to form a 5-membered ring or a 6-membered ring are shown.
JP8609991A 1991-03-25 1991-03-25 Lithographic printing plate developer Expired - Fee Related JP2938997B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8609991A JP2938997B2 (en) 1991-03-25 1991-03-25 Lithographic printing plate developer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8609991A JP2938997B2 (en) 1991-03-25 1991-03-25 Lithographic printing plate developer

Publications (2)

Publication Number Publication Date
JPH04295849A true JPH04295849A (en) 1992-10-20
JP2938997B2 JP2938997B2 (en) 1999-08-25

Family

ID=13877262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8609991A Expired - Fee Related JP2938997B2 (en) 1991-03-25 1991-03-25 Lithographic printing plate developer

Country Status (1)

Country Link
JP (1) JP2938997B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007240594A (en) * 2006-03-06 2007-09-20 Mitsubishi Paper Mills Ltd Platemaking method for photosensitive planographic printing plate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007240594A (en) * 2006-03-06 2007-09-20 Mitsubishi Paper Mills Ltd Platemaking method for photosensitive planographic printing plate

Also Published As

Publication number Publication date
JP2938997B2 (en) 1999-08-25

Similar Documents

Publication Publication Date Title
JP2868138B2 (en) Lithographic printing plate developer
JP2763415B2 (en) Lithographic printing plate developer
JPH04295849A (en) Developer for planographic printing plate
US5068164A (en) Developer with hydroxyaryl fatty acid for making lithographic printing plate
US6017673A (en) Lithographic printing plate and treating liquids for such plate comprising a hydrophilic amphoretic block copolymer
JPS6128988B2 (en)
JP2763431B2 (en) Lithographic printing plate developer
JP3296899B2 (en) Lithographic printing plate processing method
US5064745A (en) Method for making lithographic printing plate
JP3743484B2 (en) Processing method of lithographic printing plate
JP2888919B2 (en) Lithographic printing plate developer
JP2888918B2 (en) Lithographic printing plate developer
JP2935380B2 (en) Lithographic printing plate processing method
JP2000275853A (en) Treatment of lithographic printing plate
JP2866207B2 (en) New thioether compound and developer for lithographic printing plate using the same
JP3311509B2 (en) Lithographic printing plate processing method
JPH06222560A (en) Developing solution for planographic printing plate
JPS6335012B2 (en)
EP0872769B1 (en) Lithographic printing plate and treating liquids for such plate comprising a hydrophilic amphoteric block copolymer
JPH0545884A (en) Developer for planographic printing plate
JPH0588376A (en) Developer for lithographic printing plate
JPH05197155A (en) Processing method for lithographic plate
JPH0511459A (en) Developer for planographic printing
JPH0887114A (en) Processing method of offset printing plate
JPH051935B2 (en)

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees